Market Tracker

07/22 5:16pm ET

Dr.Reddy's Laboratories Ltd (NYSE:RDY)

53.34
Delayed Data
As of Jul 22
 +0.01 / +0.02%
Today’s Change
40.67
Today|||52-Week Range
68.00
+15.23%
Year-to-Date
Teva (TEVA) Provides 2016-2019 Outlook, Shares Gain
Jul 14 / Zacks.com - Paid Partner Content
Looking For Generic Drug Stocks? Pick Up These Winners
Jul 13 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close53.33
Today’s open53.41
Day’s range53.15 - 53.62
Volume177,675
Average volume (3 months)329,915
Market cap$9.1B
Dividend yield0.59%
Data as of 4:02pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-15.85%
Earnings growth (this year)--
Earnings growth (next 5 years)+8.58%
Revenue growth (last year)-2.51%
P/E ratio0.5
Price/Sales3.28
Price/Book4.70

Competitors

 Today’s
change
Today’s
% change
JAZZJazz Pharmaceuticals...-1.58-1.10%
IDXXIDEXX Laboratories I...+0.18+0.19%
MDVNMedivation Inc+0.09+0.14%
VRXValeant Pharmaceutic...-1.66-6.78%
Data as of 4:00pm ET, 07/22/2016

Financials

Last reporting dateJuly 20, 2016
EPS forecast (this quarter)$0.43
Annual revenue (last year)$2.4B
Annual profit (last year)$305.0M
Net profit margin12.94%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Co-Chairman, Chief Executive Officer &
MD
Gunupati Venkateswara Prasad
President, CFO &
Global Head-IT
Saumen Chakraborty
Corporate headquarters
Hyderabad, Telangana

Forecasts